Please login to the form below

Not currently logged in
Email:
Password:

ESMO

This page shows the latest ESMO news and features for those working in and with pharma, biotech and healthcare.

Janssen’s EGFR-targeting treatment regimen shows early benefit in lung cancer

Janssen’s EGFR-targeting treatment regimen shows early benefit in lung cancer

Positive interim results presented at 2020 ESMO virtual congress. Janssen, the pharmaceutical division of Johnson &Johnson, has revealed positive interim results from a phase 1 study of its investigational bispecific antibody ... The results, presented

Latest news

More from news
Approximately 11 fully matching, plus 49 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • ESMO 2019 – the best bits!

    Thousands of oncology professionals from around the world attended this year’s European Society for Medical Oncology (ESMO) annual meeting.

  • The 2019 WHO essential medicine list: Narrowing the access gap to innovative cancer treatments

    In 2018, The WHO Cancer Medicines Working Group (CMWG) adopted the European Society for Medical Oncology‒Magnitude of Clinical Benefit Scale (ESMO–MCBS) as a screening tool to identify cancer treatments ... The CMWG indicated that for therapies to

  • Creative review: ESMO 2018

    BLH reviews the creative concepts exhibited at the European Society for Medical Oncology (ESMO) 2018 Congress, crowning our best booth winners and giving key insights on how to develop an inspiring ... On October 19th the team from Blue Latitude Health

  • A reflection of ESMO

    Client Relationship Director Fabienne Wild from Ashfield Meetings &Events reflects on the recent conference season and on her experience at the European Society for Medical Oncology (ESMO). ... Client Relationship Director Fabienne Wild reflects on the

  • Why patient education is important in oncology

    We talked to Dr Bettina Ryll of Melanoma Patient Network Europe about changes in melanoma treatment and how the added complexity of new treatments has changed how patients need to be informed. We talked to Dr Bettina Ryll of Melanoma Patient Network

More from PMHub
Approximately 8 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...

Infographics